Medscape Medical News recently spoke with Dr. Leonard Gomella, Chair of the Department of Urology and the Director of the Sidney Kimmel Cancer Center Network, about the new guidelines from American Urological Association (AUA) and the Society of Urologic Oncology (SUO) for managing bladder cancer*.
The new guidelines affect both traditional and new therapies for treating superficial and invasive cancers. It also recommends the use of blue-light cystoscopy and stain, a technique that allows surgeons to see the multiple tumor focal points that are common in bladder cancer, even when the tumors are small and difficult to detect with regular light.
“We are doing very well with superficial bladder cancer, and we are actually doing very well with more advanced muscle-invasive bladder cancer using systemic chemotherapy and the construction of neobladders that dramatically improve quality of life for patients,” said Dr. Gomella, who is also the president of the SUO.
*Please note a subscription is required to view the article.